New cancer clinical trial: A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer

Published on: March 01, 2018 at 12:00PM
Condition:   Cancer of Prostate
Interventions:   Drug: LY01005;   Drug: Zoladex
Sponsor:   Luye Pharma Group Ltd.
Recruiting
http://ift.tt/2CU9kNb